State Food and Drug Administration: Accelerate the review and approval of drugs and medical devices, and strengthen the quality supervision of anti epidemic products

Release Time:

2022-11-15


According to the website of the National Drug Administration, on November 15th, in order to deeply implement the decisions and deployments of the Central Committee of the Communist Party of China and the State Council, and focus on the new missions and requirements proposed in the report of the 20th National Congress of the Communist Party of China, the National Drug Administration held a conference to promote foreign trade and foreign investment work, and studied and deployed measures to further strengthen the services of foreign-funded pharmaceutical enterprises and ensure the service guarantee of key foreign investment projects. Zhao Junning, a member of the Party Group and Deputy Director of the National Drug Administration, attended the meeting and delivered a speech

Zhao Junning stated that the State Food and Drug Administration attaches great importance to serving foreign trade and foreign investment work, and has issued the "Notice of the Comprehensive Department of the State Food and Drug Administration on Further Strengthening the Service Work of Foreign Investment Enterprises" and the "Notice of the Comprehensive Department of the State Food and Drug Administration on Establishing a Leading Group for Foreign Trade and Foreign Investment Coordination Work", making comprehensive arrangements for promoting foreign trade and foreign investment service work. The National Drug Administration will follow the spirit of the 20th National Congress of the Communist Party of China and, in accordance with the overall requirements of foreign trade and foreign investment services, make every effort to promote foreign trade and foreign investment services

Zhao Junning emphasized that various regions and departments should further increase their efforts in serving foreign trade and foreign investment. On the basis of doing a good job in the approval and supervision of epidemic prevention drugs and medical devices, they should accelerate the review and approval of drugs and medical devices, strengthen the quality supervision of epidemic prevention products, and solidly promote the landing and production of key foreign investment projects in medicine. Firstly, in accordance with the requirements of the relevant notice on strengthening the service work of foreign-funded enterprises, we will continue to promote the implementation and effectiveness of various work. The second is to fully utilize existing communication channels and mechanisms to gain a deeper understanding of the issues and demands of foreign business associations and foreign-funded enterprises in China. Thirdly, in accordance with the principle of locality, the national bureau shall guide the provincial bureau to ensure the service guarantee of key foreign-funded projects

All participating provincial bureaus will deeply exchange good experiences and practices around promoting foreign trade and foreign investment work in their respective regions and promoting the progress of key foreign investment projects, and clarify future work goals and measures

Officials from relevant departments, bureaus, and directly affiliated units of the State Food and Drug Administration for drugs, medical devices, and cosmetics attended the meeting on site. Officials from 11 provincial bureaus involved in key foreign-funded projects, including Tianjin, Hebei, Jilin, Shanghai, Jiangsu, Zhejiang, Fujian, Shandong, Henan, Hubei, and Guangdong, attended the meeting online through video